177 related articles for article (PubMed ID: 24842043)
1. Malignant pleural mesothelioma: a single-center experience in Turkey.
Sezer A; Sümbül AT; Abalı H; Mertsoylu H; Ozyılkan O
Med Sci Monit; 2014 May; 20():825-32. PubMed ID: 24842043
[TBL] [Abstract][Full Text] [Related]
2. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
Remon J; Nadal E; Dómine M; Ruffinelli J; García Y; Pardo JC; López R; Cilleruelo A; García-Campelo R; Martín P; Juan O; González-Larriba JL; Provencio M; Olmedo E; Ponce S; Cumplido D; Barenys C; Majem M; Massutti B; Rodriguez-Abreu D; Porta R; Sala MA; Martinez-Kareaga M; Lianes P; Reguart N
Lung Cancer; 2020 Sep; 147():83-90. PubMed ID: 32682189
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment in patients with malignant pleural mesothelioma - real life experience.
Ziółkowska B; Cybulska-Stopa B; Papantoniou D; Suwiński R
BMC Cancer; 2022 Apr; 22(1):432. PubMed ID: 35443624
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP).
Rojas L; Cardona AF; Trejo-Rosales R; Zatarain-Barrón ZL; Ramírez-Tirado LA; Ruiz-Patiño A; Campos Gómez S; Corrales L; Oblitas G; Bacon L; Martín C; de Lima VCC; Freitas HC; Mas L; Vargas C; Carranza H; Otero J; Pérez MA; González L; Chirinos L; Granados ST; Rodriguez J; Báez R; Remolina Bonilla YA; Núñez Cerrillo G; Archila P; Cuello M; Karachaliou N; Rosell R; Arrieta O;
Thorac Cancer; 2019 Mar; 10(3):508-518. PubMed ID: 30706690
[TBL] [Abstract][Full Text] [Related]
7. Pleural mesothelioma in household members of asbestos-exposed workers in Friuli Venezia Giulia, Italy.
D' Agostin F; de Michieli P; Negro C
Int J Occup Med Environ Health; 2017 May; 30(3):419-431. PubMed ID: 28481375
[TBL] [Abstract][Full Text] [Related]
8. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
Casiraghi M; Maisonneuve P; Brambilla D; Solli P; Galetta D; Petrella F; Piperno G; De Marinis F; Spaggiari L
Eur J Cardiothorac Surg; 2017 Nov; 52(5):975-981. PubMed ID: 28482086
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients.
Senyiğit A; Bayram H; Babayiğit C; Topçu F; Nazaroğlu H; Bilici A; Leblebici IH
Respiration; 2000; 67(6):615-22. PubMed ID: 11124643
[TBL] [Abstract][Full Text] [Related]
11. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases.
Yates DH; Corrin B; Stidolph PN; Browne K
Thorax; 1997 Jun; 52(6):507-12. PubMed ID: 9227715
[TBL] [Abstract][Full Text] [Related]
12. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.
Damhuis RA; Khakwani A; De Schutter H; Rich AL; Burgers JA; van Meerbeeck JP
Lung Cancer; 2015 Aug; 89(2):212-7. PubMed ID: 26044908
[TBL] [Abstract][Full Text] [Related]
14. Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
Taioli E; Wolf A; Alpert N; Rosenthal D; Flores R
J Surg Oncol; 2023 Jul; 128(1):134-141. PubMed ID: 36932968
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
[TBL] [Abstract][Full Text] [Related]
16. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
Nelson DB; Rice DC; Niu J; Atay SM; Vaporciyan AA; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao AS; Gomez DR; Giordano SH; Mehran RJ; Sepesi B
Eur J Cardiothorac Surg; 2018 May; 53(5):960-966. PubMed ID: 29211849
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
Zalcman G; Mazieres J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Rivière F; Janicot H; Gervais R; Locher C; Milleron B; Tran Q; Lebitasy MP; Morin F; Creveuil C; Parienti JJ; Scherpereel A;
Lancet; 2016 Apr; 387(10026):1405-1414. PubMed ID: 26719230
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
[TBL] [Abstract][Full Text] [Related]
19. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
20. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
